ロード中...
Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
Over the past decade, patients with advanced non-small-cell lung cancer (NSCLC) have witnessed substantial advances in regards to therapeutic alternatives. Among newly developed agents, angiogenesis inhibitors were extensively tested in different settings and have produced some favorable outcomes de...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5372785/ https://ncbi.nlm.nih.gov/pubmed/28424759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00052 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|